Fat loss prompts SA treatment switch.
D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000627:therapeutic use; D015992:Body Mass Index; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D008060:Lipodystrophy / Q000139:chemically induced*; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects*
D019380:Anti-HIV Agents; D018894:Reverse Transcriptase Inhibitors